[1]
T. Aritajati, C. . Chayakul, and S. . Tongyoo, “Terlipressin for refractory septic shock: a study protocol of a single center, placebo-controlled double-blind phase III RCT (The TERESEP study)”., Clin Crit Care, vol. 30, p. 2022:e0003, Mar. 2022.